Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
Authors
Keywords
-
Journal
Epigenetics & Chromatin
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-16
DOI
10.1186/s13072-019-0267-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
- (2019) Sonia Mediouni et al. mBio
- Targeting the Latent Reservoir for HIV-1
- (2018) Srona Sengupta et al. IMMUNITY
- Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
- (2018) Emilie Battivelli et al. eLife
- The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes
- (2017) Ryan J. Conrad et al. MOLECULAR CELL
- Underlying mechanisms of HIV-1 latency
- (2017) Bizhan Romani et al. VIRUS GENES
- Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency
- (2017) Maxime Jean et al. Viruses-Basel
- In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment
- (2017) Cari F. Kessing et al. Cell Reports
- The Molecular Basis for Human Immunodeficiency Virus Latency
- (2017) Uri Mbonye et al. Annual Review of Virology
- Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency
- (2016) Guannan Geng et al. MOLECULAR THERAPY
- Shock and kill with caution
- (2016) R. C. Gallo SCIENCE
- Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
- (2016) Mateusz Stoszko et al. EBioMedicine
- A Hardwired HIV Latency Program
- (2015) Brandon S. Razooky et al. CELL
- Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
- (2015) Sonia Mediouni et al. CURRENT HIV RESEARCH
- The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
- (2015) Guillaume Mousseau et al. mBio
- HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
- (2015) Leonard Chavez et al. PLoS Pathogens
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- Epigenetic control of HIV-1 post integration latency: implications for therapy
- (2015) Amit Kumar et al. Clinical Epigenetics
- The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
- (2015) Sonia Mediouni et al. Frontiers in Microbiology
- Negative Elongation Factor Is Required for the Maintenance of Proviral Latency but Does Not Induce Promoter-Proximal Pausing of RNA Polymerase II on the HIV Long Terminal Repeat
- (2014) J. K. Jadlowsky et al. MOLECULAR AND CELLULAR BIOLOGY
- HIV latency and integration site placement in five cell-based models
- (2013) Scott Sherrill-Mix et al. Retrovirology
- An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
- (2012) Guillaume Mousseau et al. Cell Host & Microbe
- The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency
- (2012) D. A. Donahue et al. JOURNAL OF VIROLOGY
- Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans
- (2012) Karen Adelman et al. NATURE REVIEWS GENETICS
- Influence of Host Gene Transcription Level and Orientation on HIV-1 Latency in a Primary-Cell Model
- (2011) L. Shan et al. JOURNAL OF VIROLOGY
- Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
- (2011) J. Friedman et al. JOURNAL OF VIROLOGY
- Global landscape of HIV–human protein complexes
- (2011) Stefanie Jäger et al. NATURE
- Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65
- (2011) Giuseppe Fiume et al. NUCLEIC ACIDS RESEARCH
- Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency
- (2011) Haleh Rafati et al. PLOS BIOLOGY
- Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294
- (2010) Kenichi Imai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction
- (2010) M. Tyagi et al. JOURNAL OF VIROLOGY
- Transcription through the HIV-1 nucleosomes: Effects of the PBAF complex in Tat activated transcription
- (2010) Rebecca Easley et al. VIROLOGY
- The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
- (2010) Jonathan Karn Current Opinion in HIV and AIDS
- Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
- (2009) Nancie M Archin et al. AIDS
- Predicting nucleosome positions on the DNA: combining intrinsic sequence preferences and remodeler activities
- (2009) Vladimir B. Teif et al. NUCLEIC ACIDS RESEARCH
- In vitro nuclear interactome of the HIV-1 Tat protein
- (2009) Virginie W Gautier et al. Retrovirology
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now